Search

everythinglearnresearchcommunity

for

Search:↓

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

Using 5α-reductase inhibitors for hair loss may increase the risk of dry eye disease.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

A new compound from a sponge strongly inhibits an enzyme linked to male-pattern hair loss without being toxic at low levels.

Phenytoin and spironolactone help prevent hair loss from chemotherapy by reducing stress and inflammation.

New tests detect finasteride and dutasteride in urine quickly and easily.

Certain medications, especially 5-alpha reductase inhibitors, are commonly linked to erectile dysfunction.

Urologists prescribe newer medications more often than primary care physicians, who could benefit from more education on treatment options.

MK-386 lowers DHT in blood and skin but not in semen.

Letrozole may help prevent seizures by reducing certain hormone levels.

Long-term use of a drug for hair loss and prostate issues can cause metabolic problems and depression-like behavior in young male rats.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

5α-reductase inhibitors like finasteride may not be effective or safe for transgender individuals, and more research is needed.

Higher doses of 5α-reductase inhibitors may lower mortality risk, but low doses increase it.

The research helps understand how finasteride works and aids drug development.

Setipiprant may reduce inflammation by blocking an enzyme called aldose reductase.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Raltegravir may cause hair loss in some patients.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Aromatase inhibitors can cause various adverse reactions, so monitoring is crucial.